Jul 20, 2023
New report analyzes the patient impact of growing coverage restrictions for FDA accelerated approval treatments. WASHINGTON — Patients Rising, a non-profit organization that champions patients with chronic and rare diseases, today released a special report titled CMS...
Jun 8, 2023
WASHINGTON – Patients Rising, a non-profit organization advocating on behalf of patients with chronic and rare diseases, today released Principles for CMS on Harnessing the Power of Patient Involvement When Implementing the Inflation Reduction Act. The principles are...
Jun 2, 2023
In mid-May, the U.S. Supreme Court opted not to take up a patent-infringement case between two pharmaceutical companies – Teva and GlaxoSmithKline (GSK). While it largely went unnoticed among those who are not patent lawyers, IP nerds, or drug companies, the...
May 17, 2023
By Dr. Robert Popovian, Erin Delaney, and Dr. Michael Mandel We may be on the verge of a titanic shift in how drug prices are set. It’s been led by a dramatic decline in insulin prices, but it’s spreading to other brand drugs as well. This new paradigm is the...
May 16, 2023
By MacKay Jimeson Some of the most exciting advances in science and medicine are happening in Alzheimer’s, a disease that is one of the greatest epidemics of this generation. Eli Lilly announced promising results last week for experimental amyloid-targeting drug...
Apr 20, 2023
Ohio the latest state to legally challenge the business model of Pharmacy Benefit Mangers (PBMs). Last month, the state’s attorney general filed a landmark lawsuit alleging that Express Scripts and Prime Therapeutics – two of the country’s largest PBMs – illegally...
